Dr. John Buchanan serves as the President and CEO for the Center for Aquaculture Technologies (CAT), a team with a corporate strategy of maintaining excellence in contract research and innovative R&D in aquaculture biotechnology. Prior to helping launch CAT, Dr. Buchanan spent 5 years as the Director of Research and Development at AquaBounty Technologies. Previously, Dr. Buchanan has held a series of research leadership positions at Louisiana State University, the University of California at San Diego School of Medicine, and Kent SeaTech Corporation. Dr. Buchanan has led research on the application of genetic engineering to aquaculture, the use of selective breeding, hatchery technologies, and genomics for improved productivity in finfish, the development of novel therapeutics for aquaculture, and the molecular and genetic basis for virulence in aquatic and human pathogens. He also has experience directing and conducting studies compliant with governmental regulatory standards (GLP/GCP). Dr. Buchanan completed his undergraduate work at Texas A&M University with a B.S. in Zoology, and received his Ph.D. in Oceanography from Louisiana State University with a focus on marine biotechnology.Specialties: business development, corporate strategy, genetic engineering, infectious disease, molecular microbiology, vaccine development, biotechnology, molecular biology, ploidy manipulation, cryopreservation, GLP, GCP, regulatory studies